Others

Code of Conduct of Fair Disclosure

| Updated on May 22, 2015 Published on May 22, 2015

Lifeline Drugs & Pharma Ltd has informed BSE that Board of Directors of the Company in their meeting held on May 14, 2015 have formulated and adopted Code for Fair Disclosure and Code of Conduct as per Regulation 8(1) and 9(1)
of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

As required by Regulation 8(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Company has submitted to BSE the Code for Fair Disclosure and Code of Conduct. This will also be published on Company website.

Pdf Link: >Code of Conduct of Fair Disclosure

Source : BSE - >www.bseindia.com

Published on May 22, 2015
This article is closed for comments.
Please Email the Editor